Cardiovascular disease (CVD) is the leading cause of disease-related death worldwide and
a significant obstacle to improving patients' health and lives. Mitochondria are core …

MicroRNAs (miRNAs), small noncoding RNAs, are post-transcriptional gene regulators that
can promote the degradation or decay of coding mRNAs, regulating protein synthesis. Many …

Breast cancer patients are at a particularly high risk of cardiotoxicity from chemotherapy
having a detrimental effect on quality-of-life parameters and increasing the risk of mortality …

Myocardial fibrosis, resulting from the disturbance of extracellular matrix homeostasis in
response to different insults, is a common and important pathological remodeling process …

Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy and is
characterized by increased left ventricular wall thickness, but existing diagnostic and …

Cardiac fibrosis is a significant global health problem associated with almost all types of
heart disease. Extensive cardiac fibrosis reduces tissue compliance and contributes to …

Hypertrophic cardiomyopathy (HCM) is the most common inherited myocardial disease with
significant genetic and phenotypic heterogeneity. To search for novel biomarkers, which …

Myocardial fibrosis involves the loss of cardiomyocytes, myocardial fibroblast proliferation,
and a reduction in angiogenesis, ultimately leading to heart failure, Given its significant …

Contemporary breast cancer management includes surgical resection combined with a
multimodal approach, including chemotherapy, radiotherapy, endocrine therapy, and …

Idiopathic pulmonary fibrosis (IPF) constitutes a long-term disease with a complex
pathophysiology composed of multiple molecular actors that lead to the deposition of …